Section 7.1 Laboratory
Laboratory Report #33
Date
Collection Date: August 12, 2024
Report Date: August 13, 2024
Laboratory
Labcorp
Ordering Physician
Dr. Billy R. Boring, Jr.
Report Type
Follow-up CBC and Metabolic Monitoring Evaluation
Laboratory testing included:
- Complete Blood Count (CBC) with Platelets (No Differential)
- Hemoglobin A1c
Original Report
PDF: Labcorp – August 12, 2024
One-Page Summary
Purpose of Testing
This focused laboratory evaluation was performed approximately six weeks after the comprehensive June 2024 laboratory study. The purpose was to reassess two important areas:
- Persistent mild normocytic anemia
- Glucose/metabolic improvement following dietary changes
The report provides an important follow-up point after the June 2024 findings. It shows that the anemia remained stable without further decline and that metabolic control continued to improve significantly.
Major Findings
1. Complete Blood Count (CBC)
Results
| Test | Result | Interpretation |
|---|---|---|
| WBC | 5.2 ×10³/µL | Normal |
| RBC | 3.71 ×10⁶/µL | Low |
| Hemoglobin | 11.3 g/dL | Low |
| Hematocrit | 36.1% | Low |
| MCV | 97 fL | Normal |
| MCH | 30.5 pg | Normal |
| MCHC | 31.3 g/dL | Slightly Low |
| RDW | 13.0% | Normal |
| Platelets | 197 ×10³/µL | Normal |
Interpretation
The CBC demonstrates persistent but stable mild normocytic anemia.
Comparison with June 26, 2024:
| Marker | June 2024 | August 2024 |
|---|---|---|
| RBC | 3.71 | 3.71 |
| Hemoglobin | 11.2 | 11.3 |
| Hematocrit | 35.4% | 36.1% |
| MCV | 95 | 97 |
| Platelets | 191 | 197 |
The important observation is that the anemia did not worsen.
The pattern remains:
- Mild
- Normocytic
- Stable
- Isolated to red blood cells
White blood cells and platelets remain normal, suggesting no evidence of generalized bone marrow suppression.
Historical Hemoglobin Trend
The Labcorp historical chart on page 2 illustrates the longer-term pattern:
| Date | Hemoglobin |
|---|---|
| July 2023 | 11.8 |
| September 2023 | 11.3 |
| November 2023 | 13.1 |
| June 2024 | 11.2 |
| August 2024 | 11.3 |
Interpretation of Trend
The chart demonstrates:
- A temporary recovery in November 2023.
- Return of anemia in June 2024.
- Stability through August 2024.
This suggests a recurring pattern rather than a rapidly progressive decline.
2. Hemoglobin A1c
Result
Hemoglobin A1c
- 5.4%
Reference Range:
- 4.8–5.6%
Interpretation
This is an excellent metabolic finding.
Trend:
| Date | A1c |
|---|---|
| January 2022 | 5.6% |
| December 2022 | 5.7% |
| June 2023 | 5.6% |
| September 2023 | 5.8% |
| August 2024 | 5.4% |
The A1c has returned to the normal range and represents the lowest value in the recent trend.
This improvement is consistent with the major dietary changes beginning January 2024.
Overall Interpretation
This August 2024 follow-up report provides two important conclusions:
1. Hematologic Status
The anemia remains present but stable.
- Hemoglobin improved slightly from 11.2 → 11.3 g/dL.
- Hematocrit improved from 35.4% → 36.1%.
- Platelets and WBC remain normal.
There is no evidence in this report of rapid progression.
2. Metabolic Health
Glucose regulation continues to improve.
- Hemoglobin A1c decreased to 5.4%.
- This is the best A1c value documented in the available recent trend.
Longitudinal Significance
This report contributes to:
- CBC Trend Table
- Hemoglobin Trend Table
- Hematocrit Trend Table
- Platelet Trend Table
- Hemoglobin A1c Trend Table
- Lifestyle & Diet Impact Timeline
- Medical History Timeline
Clinical Importance
⭐⭐⭐⭐ Stability Confirmation Report
This report is important because it answers two questions raised by the June 2024 laboratory evaluation:
Question 1:
Is the anemia getting worse?
Answer:
No. It remained essentially unchanged.
Question 2:
Are metabolic improvements continuing?
Answer:
Yes. A1c improved to 5.4%.
Key Findings
- Hemoglobin: 11.3 g/dL (Low)
- Hematocrit: 36.1% (Low)
- RBC: 3.71 ×10⁶/µL (Low)
- MCV: 97 fL (Normal)
- WBC: 5.2 ×10³/µL (Normal)
- Platelets: 197 ×10³/µL (Normal)
- Hemoglobin A1c: 5.4% (Normal)
Related Reports
- June 26, 2024 – Comprehensive Health Evaluation
- November 13, 2023 – Recovery Evaluation
- September 12, 2023 – Anemia Evaluation
- July 19, 2023 – CBC Follow-up
- CBC Trend Table
- Hemoglobin Trend Table
- Metabolic Health Trend Table
Navigation
- Previous Report: June 26, 2024 – Comprehensive Health Evaluation
- Next Report: November 12, 2024 – Laboratory Evaluation
- Return to Laboratory Library
- Return to Health Inventory
Observation
This small but focused report is valuable because it confirms a pattern that is becoming clearer in your Health Inventory:
The inflammatory markers and metabolic markers are improving, while the anemia remains an isolated issue.
The combination of:
- Normal iron stores
- Normal B12 and folate
- Normal kidney function
- Very low CRP
- Stable CBC pattern
suggests that the anemia deserves continued observation but is not currently accompanied by signs of active systemic illness.
The most encouraging finding is the continued metabolic improvement:
- A1c 5.8% (September 2023)
- A1c 5.4% (August 2024)
This provides a measurable laboratory marker of the positive impact of your lifestyle changes.